免疫检查点抑制剂诱导的嗜酸性肝浸润一例:18F-FDG高摄取与68Ga-FAPI-04低摄取
一例70岁男性左肺下叶鳞癌根治术后4年、因疑诊肺门淋巴结转移接受信迪利单抗治疗3个月后,MRI发现多发肝病灶。实验室检查嗜酸性粒细胞计数异常升高至4.89×10^9/L。18F-FDG PET/CT示肝病灶FDG高摄取,68Ga-FAPI-04 PET/MRI示轻度FAPI摄取;肝活检示慢性肉芽肿性炎伴坏死及大量嗜酸性粒细胞,诊断为免疫检查点抑制剂诱导的嗜酸性肝浸润。
要点
- 免疫检查点抑制剂治疗后出现肝病灶时,需考虑嗜酸性肝浸润的可能。
- 18F-FDG PET/CT示肝病灶FDG高摄取,而68Ga-FAPI-04 PET/MRI仅示轻度摄取。
- 肝活检示慢性肉芽肿性炎伴坏死及大量嗜酸性粒细胞,结合病史可确诊。
核心结论
- 结合影像学与肝活检结果,本例诊断为免疫检查点抑制剂诱导的嗜酸性肝浸润。
研究设计与样本
- 本文为个案报告,报道一例70岁男性左肺下叶鳞癌根治术后4年、因疑诊肺门淋巴结转移接受信迪利单抗治疗3个月后出现多发肝病灶的病例。
主要发现
- MRI发现多发肝病灶,实验室检查示嗜酸性粒细胞计数异常升高至4.89×10^9/L。
- 18F-FDG PET/CT示肝病灶FDG高摄取,68Ga-FAPI-04 PET/MRI示轻度FAPI摄取。
- 肝活检示慢性肉芽肿性炎伴坏死及大量嗜酸性粒细胞。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
A 70-year-old man, who underwent radical surgery for left lower lung squamous cell carcinoma 4 years ago and received sintilimab therapy 3 months ago for suspected hilar lymph node metastasis, presented with multiple liver lesions detected by MRI. Laboratory tests showed abnormally elevated eosinophil count with 4.89×10 9 /L. 18 F-FDG PET/CT imaging demonstrated significantly high FDG-avid in the liver lesions, while 68 Ga-FAPI-04 PET/MRI imaging revealed slight FAPI uptake. Histopathological examination of the liver biopsy indicated chronic granulomatous inflammation with necrosis and a large number of eosinophils. Combining with these tests, eosinophilic liver infiltration induced by the immune checkpoint inhibitor was diagnosed.
引用
- Sun Y, Zhao J, You Z, et al. High 18 F-FDG and Low 68 Ga-FAPI-04 Activity in a Case of Eosinophilic Liver Infiltration Induced by Immune Checkpoint Inhibitor. Clin Nucl Med. 2025. PMID: 40982801. doi:10.1097/RLU.0000000000006087
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。